Research on Receptor Protein-Tyrosine Kinases Described by Researchers at University of Texas MD Anderson Cancer Center (Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L)

Press/Media

Period11 May 2023

Media coverage

1

Media coverage